Video Experimental Relacionado
Updated: Feb 28, 2026
15:04
Potentiation of Anticancer Antibody Efficacy by Antineoplastic Drugs: Detection of Antibody-drug Synergism Using the Combination Index Equation
Published on: January 19, 2019
12.9K
Estrategias de Combinación Estratégica en Inmunoterapia contra el Cáncer
1Dept. of Thoracic Oncology, National Cancer Center Hospital.
Gan to kagaku ryoho. Cancer & chemotherapy
|February 26, 2026
Resumen
Los inhibidores de puntos de control inmunitario (ICI) muestran promesa en la terapia contra el cáncer pero a menudo enfrentan resistencia. La combinación de ICI con otros tratamientos como quimioterapia o conjugados anticuerpo-fármaco puede mejorar la eficacia y la inmunidad antitumoral.
Área de la Ciencia:
- Oncología
- Inmunoterapia
- Investigación sobre el cáncer
Sus antecedentes:
- Los inhibidores de puntos de control inmunitario (ICI) han revolucionado el tratamiento del cáncer, especialmente para el cáncer de pulmón no microcítico.
- La monoterapia con ICI presenta una eficacia limitada debido a la resistencia tumoral y a un microambiente tumoral inmunosupresor.
Objetivo del estudio:
- Revisar la justificación y la evidencia clínica para combinar los ICI con otras modalidades terapéuticas.
- Destacar los desafíos y las direcciones futuras en la inmunoterapia personalizada.
Principales métodos:
- Revisión de la literatura sobre los avances recientes en inmunoterapia contra el cáncer.
- Análisis de la evidencia clínica que respalda las estrategias de combinación.
- Discusión de los desafíos en el desarrollo de biomarcadores y el manejo de la toxicidad.
Principales resultados:
- Las estrategias de combinación, incluida la quimioterapia, los agentes dirigidos, el bloqueo dual de puntos de control, los conjugados anticuerpo-fármaco (ADC) y la radioterapia, muestran potencial para mejorar la inmunidad antitumoral.
- Estas combinaciones tienen como objetivo superar la resistencia y mejorar los resultados de los pacientes.
Conclusiones:
- Las terapias combinadas representan un enfoque prometedor para mejorar la eficacia de los ICI en el tratamiento del cáncer.
- Abordar los desafíos en biomarcadores, toxicidad y secuenciación del tratamiento es crucial para avanzar en la inmunoterapia personalizada.
Palabras clave:
inmunoterapia contra el cáncerinhibidores de puntos de control inmunitarioterapias combinadasresistencia al cáncerinmunidad antitumoralquimioterapiaconjugados anticuerpo-fármacoMás Videos Relacionados
Videos de Conceptos Relacionados
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
02:50Combination Therapies and Personalized Medicine
6.2K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.2K
01:30Cancer Vaccines
1.2K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.2K
02:57Targeted Cancer Therapies
9.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.0K
02:49Cancer Therapies
10.3K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.3K
02:56Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K